Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.（AUPH）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
auph · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$16.00
Consensus
$12.60
-21.1% upside
Low
$6.00
Median: $13 · Last Close: $15.97
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$12.60
-21.1% upside
High Target
$16
0.2%
Low Target
$6
-62.4%
Current Price
$15.97
as of today
Based on analyst price targets, the AUPH stock price prediction for the next 12 months ranges from $6 to $16. The consensus AUPH price forecast of $12.60 implies -21.1% upside from the current price of $15.97.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $16.12 | ↑ 0.92% |
1-day model range: $16.05–$16.19. Peak: $16.19 (+0.92%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +11.7% |
| 2028 | $19 | +19.6% |
| 2029 | $20 | +24.6% |
| 2030 | $20 | +27.8% |
| 2031 | — | +29.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AUPH · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-11-07 | Jefferies | Upgrade ↑ | Hold→Buy |
| 2025-11-05 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2025-08-01 | RBC Capital | Maintains | Outperform→Outperform |
| 2024-09-16 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-09-09 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-09-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-23 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-02-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aurinia Pharmaceuticals Inc. (AUPH) stock. Of the recent 53 rating actions, 2 were upgrades and 4 were downgrades. 14 analysts currently cover AUPH.
分析师推荐趋势
AUPH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$326M
↓ 26.6% YoY
Revenue Next Year
$384M
↑ 17.8% YoY
EPS This Year
$0.91
EPS Next Year
$1.11
↑ 22.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast AUPH EPS of $0.91 for the current fiscal year, based on estimates from 4 analysts. The AUPH revenue forecast is $326M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AUPH 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AUPH 的共识目标价为 $12.60（-21.1% 上行空间），分析师共识为 Buy。
AUPH 的短期预测（明日）为 $16.12（+0.92%）。 AUPH 对 2027 年的股价预测均值为 $18。 AUPH 对 2030 年的预测区间为 $19–$21。
Aurinia Pharmaceuticals Inc. 在 NASDAQ 上市，代码 AUPH。AUPH 在 2027 年的整体展望偏积极，在覆盖分析师中约 79% 对应 Buy 共识。
常见问题
AUPH 预测 · 8 个问题根据 14 位华尔街分析师，AUPH 的 12 个月平均目标价为 $12.60，最高 $16.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $15.97，隐含约 -21.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.